Bottom line
How much do PRHSX and IXJ overlap?
70% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 57.0% of PRHSX's assets and 51.4% of IXJ's. They are largely the same portfolio — owning both adds little diversification.
PRHSX holds far more positions (279 vs 124), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PRHSX and IXJ have in common
| Holding | % of PRHSX | % of IXJ | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 14.28% | 10.93% | 10.93% |
| Johnson & Johnson | 6.63% | 7.04% | 6.63% |
| Unitedhealth Group Inc | 5.99% | 4.40% | 4.40% |
| Abbvie Inc | 5.10% | 5.12% | 5.10% |
| Merck & Co. Inc. | 4.01% | 4.12% | 4.01% |
| Gilead Sciences Inc | 2.82% | 2.04% | 2.04% |
| Thermo Fisher Scientific Inc | 2.52% | 2.42% | 2.42% |
| Vertex Pharmaceuticals Inc | 2.28% | 1.64% | 1.64% |
| Bristol-myers Squibb Co | 2.11% | 1.53% | 1.53% |
| Abbott Laboratories | 1.89% | 2.05% | 1.89% |
| Intuitive Surgical Inc | 1.87% | 1.83% | 1.83% |
| Amgen Inc | 1.82% | 2.54% | 1.82% |
| Stryker Corp | 1.78% | 1.41% | 1.41% |
| Elevance Health Inc | 1.53% | 1.09% | 1.09% |
| Danaher Corp | 1.43% | 1.56% | 1.43% |
| Cvs Health Corp | 0.94% | 1.71% | 0.94% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PRHSX
- Natera Inc — 1.44%
- Guardant Health Inc — 1.23%
- Cardinal Health Inc — 1.03%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
- Brightspring Health Services — 0.82%
Only in IXJ
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Novo Nordisk A/s — 1.99%
- Pfizer Inc. — 1.78%
- Gsk Plc — 1.38%
- Medtronic Public Limited Company — 1.30%
- Sanofi Sa — 1.18%
- Mckesson Corporation — 1.18%
Asset mix
| Asset type | PRHSX | IXJ |
|---|---|---|
| Stocks | 96.4% | 99.6% |
| Preferred stock | 3.0% | — |
| Cash & short-term funds | 0.7% | 1.3% |
| Bonds | 0.2% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | PRHSX | IXJ |
|---|---|---|
| US | 92.6% | 70.6% |
| CH | 0.5% | 10.4% |
| GB | 1.7% | 5.8% |
| JP | 0.5% | 3.7% |
| DK | 0.7% | 2.3% |
| FR | 0.2% | 2.0% |
| DE | — | 1.6% |
| IE | 0.8% | 1.6% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do PRHSX and IXJ overlap?
What stocks do PRHSX and IXJ have in common?
Should I own both PRHSX and IXJ?
Which holds more stocks, PRHSX or IXJ?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.